PK and Safety of DWJ1451 vs Co-administration of DWC202008 and DWC202009 in Healthy Volunteers

Phase 1, randomised, open-label trial of olmesartan, amlodipine, rosuvastatin and ezetimibe in hypertension (HTN) and hyperlipidemia (2 arms), sponsored by Daewoong Pharmaceutical. Primary endpoints: Area Under the Concentration-time Curve From Time Zero to Time t and Maximum Plasma Concentration. Status: unknown.